Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife Issues

February 2024

April 2024

May 2024

June 2024

October 2024

ONCOLife Articles

How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment

20 November 2024

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview with Dr. Thomas C. Heineman, CMO at Oncolytics Biotech, we explore the groundbreaking potential of oncolytic viruses....

Transforming Melanoma Treatment with DNA Plasmid Vaccine

ONCOLife | 28 October 2024

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

ONCOLife | 15 October 2024

AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma

FDA & EMA | 17 October 2024

FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer

FDA & EMA | 19 October 2024

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

ONCOLife | 12 October 2024

Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries

Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform

ONCOLife

9 October 2024

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife

9 October 2024

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

ONCOLife

7 October 2024

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

ONCOLife

3 October 2024


About Image

About ONCOLife

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.